Adrenocortical carcinoma: Many questions remain unanswered

Endocrinologist

Volumn 15, Issue 5, 2005, Pages 309-312

  Geller, Jordan L ^a   Mertens, Richard B ^a   Weiss, Lawrence M ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adrenal carcinoma; Adrenal malignancy; Adrenocortical carcinoma; Cushing syndrome; Endocrine neoplasms

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; AMINOGLUTETHIMIDE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOMIDATE; ETOPOSIDE; FLUOROURACIL; KETOCONAZOLE; MITOTANE; STREPTOZOCIN; VINCRISTINE;

ADRENAL BIOPSY; ADRENAL CORTEX CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RARE DISEASE; REVIEW; SIDE EFFECT;

EID: 25844526508     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000179019.26435.ad     Document Type: Review

References (36)

1. National Cancer Institute, National Institutes of Health. Available at: www.nci.nih.gov/cancertopics/pdq/treatment/adrenocortical. Accessed March 30, 2005.
2. Stojadinovic A, Ghossein RA, Hoos A, et al. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol. 2002;20:941-950.
3. Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol. 2003;169:5-11.
4. Allolio B, Hahner S, Weismann D, et al. Management of adrenocortical carcinoma. Clin Endocrinol (Oxf). 2004;60:273-287.
5. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000;88:711-736.
6. Sameshima Y, Tsunematsu Y, Watanabe S, et al. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. J Natl Cancer Inst. 1992;84:703-707.
7. Reincke M, Karl M, Travis WH, et al. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab. 1994;78:790-794.
8. Lin SR, Lee YJ, Tsai JH. Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab. 1994;78:483-491.
9. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA. 2001;98:9330-9335.
10. Hyodo T, Megyesi K, Kahn CR, et al. Adrenocortical carcinoma and hypoglycemia: evidence for production of nonsuppressible insulin-like activity by the tumor. J Clin Endocrinol Metab. 1977;44:1175-1184.
11. Zapf J, Futo E, Peter M, et al. Can 'big' insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest. 1992;90:2574-2584.
12. Harrison LE, Gaudin PB, Brennan MF. Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg. 1999;134:181-185.
13. Zografos GC, Driscoll DL, Karakousis CP, et al. Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol. 1994;55:160-164.
14. Hutter AM Jr, Kayhoe DE. Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med. 1966;41:572-580.
15. Lack EE: Pathology of the adrenal cortex. In: Lechago J, Gould V, eds. Bloodworth's Endocrine Pathology, 3rd ed. Baltimore: Williams & Wilkins; 1997:382-406.
16. Aron DC, Findling JW, Tyrrell JB. Glucocorticoids & adrenal androgens. In: Greenspan FS, Gardne DG, eds. Basic and Clinical Endocrinology, 7th ed. New York: Lange Medical Books; 2004:366-373.
17. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med. 1990;323:1401-1405.
18. Angeli A, Osella G, Ali A, et al. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res. 1997;47:279.
19. Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol. 1996;167:861.
20. Fassnacht M, Kenn W, Allolio B. Adrenal tumors: how to establish malignancy? J Endocrinol Invest. 2004;27:387-399.
21. Dunnick NR. Adrenal carcinoma. Radiol Clin North Am. 1994;32:99-108.
22. Paulsen SD, Nghiem HV, Korobkin M, et al. Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies. AJR Am J Roentgenol. 2004;182:1033-1037.
23. Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989;13:202-206.
24. Iino K, Oki Y, Sasano H. A case of adrenocortical carcinoma associated with recurrence after laparoscopic surgery. Clin Endocrinol (Oxf). 2000;53:243-248.
25. Ushiyama T, Suzuki K, Kageyama S, et al. A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy. J Urol. 1997;157:2239.
26. Nelson JB, Kavoussi LR, Walther MM. A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy. J Urol. 1998;159:1310.
27. Tsivian A, Sidi AA. Port site metastases in urological laparoscopic surgery. J Urol. 2003;169:1213-1218.
28. Iacconi P, Bendinelli C, Miccoli P, et al. A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy. J Urol. 1999;161:1580-1581.
29. Pasieka JL. What's new in general surgery: endocrine surgery. J Am Coll Surg. 2004;199:437-445.
30. Moinzadeh A, Gill IS. Laparoscopic radical adrenalectomy for malignancy in 31 patients. J Urol. 2005;173:519-525.
31. Foxius A, Ramboux A, Lefebvre Y, et al. Hazards of laparoscopic adrenalectomy for Conn's adenoma. When enthusiasm turns to tragedy. Surg Endosc. 1999;7:715-717.
32. Outwater EK, Mitchell DG, Rubenfeld IG. Correction to a previously published case: recurrence of invasive adrenocortical tumor after excision of atypical adenoma. Radiology. 1997;202:531-532.
33. de Fraipont F, Atifi ME, Cherradi N, et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab. 2005;90:1819-1829.
34. Bornstein SR, Hornsby PJ. What can we learn from gene expression profiling for adrenal tumor management? J Clin Endocrinol Metab. 2005;90:1900-1902.
35. Van Aalderen W, Van Seters AP, Backer ET, et al. A case of recurrent adrenocortical carcinoma, with observations on long-term o,p′-DDD therapy and complications. Neth J Med. 2002;41:161-170.
36. Markoe AM, Serber W, Micaily B, et al. Radiation therapy for adjunctive treatment of adrenal cortical carcinoma. Am J Clin Oncol. 1991;14:170-174.